These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 35110228)

  • 1. Efficacy of High-Dose Nebulized Interferon α 2b in Severe COVID-19 Pneumonia.
    Chkhis A; Abdulrazzaq N; Mokhtar S; Jasmi AA
    Turk Thorac J; 2021 May; 22(3):199-204. PubMed ID: 35110228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-α-2b aerosol inhalation is associated with improved clinical outcomes in patients with coronavirus disease-2019.
    Yu J; Lu X; Tong L; Shi X; Ma J; Lv F; Wu J; Pan Q; Yang J; Cao H; Li L
    Br J Clin Pharmacol; 2021 Dec; 87(12):4737-4746. PubMed ID: 33982806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b-Literature Review and Personal Preliminary Experience.
    Mary A; Hénaut L; Macq PY; Badoux L; Cappe A; Porée T; Eckes M; Dupont H; Brazier M
    Front Pharmacol; 2020; 11():592543. PubMed ID: 33329000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
    Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
    Front Immunol; 2021; 12():648004. PubMed ID: 33767713
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Intubation Timing on the Outcome of Patients With Severe Respiratory Distress Secondary to COVID-19 Pneumonia.
    Fayed M; Patel N; Yeldo N; Nowak K; Penning DH; Vasconcelos Torres F; Natour AK; Chhina A
    Cureus; 2021 Nov; 13(11):e19620. PubMed ID: 34804753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chest X-ray radiologic severity index as a determinant of the severity of COVID-19 pneumonia: study based on the duration of treatment and inpatient rooms.
    Satoto B; Handoyo T; Sari MNW; Santoso AG; Prasetyo NE
    Chin J Acad Radiol; 2023; 6(1):10-17. PubMed ID: 36474596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
    Kremsner PG; Ahuad Guerrero RA; Arana-Arri E; Aroca Martinez GJ; Bonten M; Chandler R; Corral G; De Block EJL; Ecker L; Gabor JJ; Garcia Lopez CA; Gonzales L; Granados González MA; Gorini N; Grobusch MP; Hrabar AD; Junker H; Kimura A; Lanata CF; Lehmann C; Leroux-Roels I; Mann P; Martinez-Reséndez MF; Ochoa TJ; Poy CA; Reyes Fentanes MJ; Rivera Mejia LM; Ruiz Herrera VV; Sáez-Llorens X; Schönborn-Kellenberger O; Schunk M; Sierra Garcia A; Vergara I; Verstraeten T; Vico M; Oostvogels L;
    Lancet Infect Dis; 2022 Mar; 22(3):329-340. PubMed ID: 34826381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19.
    Davoudi-Monfared E; Rahmani H; Khalili H; Hajiabdolbaghi M; Salehi M; Abbasian L; Kazemzadeh H; Yekaninejad MS
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32661006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.
    Hess CB; Buchwald ZS; Stokes W; Nasti TH; Switchenko JM; Weinberg BD; Steinberg JP; Godette KD; Murphy D; Ahmed R; Curran WJ; Khan MK
    Cancer; 2020 Dec; 126(23):5109-5113. PubMed ID: 32986274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Coronavirus Disease 2019 Patients With Prolonged Postsymptomatic Viral Shedding With Leflunomide: A Single-center Randomized Controlled Clinical Trial.
    Wang M; Zhao Y; Hu W; Zhao D; Zhang Y; Wang T; Zheng Z; Li X; Zeng S; Liu Z; Lu L; Wan Z; Hu K
    Clin Infect Dis; 2021 Dec; 73(11):e4012-e4019. PubMed ID: 32955081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumonia.
    Zieleskiewicz L; Markarian T; Lopez A; Taguet C; Mohammedi N; Boucekine M; Baumstarck K; Besch G; Mathon G; Duclos G; Bouvet L; Michelet P; Allaouchiche B; Chaumoître K; Di Bisceglie M; Leone M;
    Intensive Care Med; 2020 Sep; 46(9):1707-1713. PubMed ID: 32728966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
    Diaz R; Orlandini A; Castellana N; Caccavo A; Corral P; Corral G; Chacón C; Lamelas P; Botto F; Díaz ML; Domínguez JM; Pascual A; Rovito C; Galatte A; Scarafia F; Sued O; Gutierrez O; Jolly SS; Miró JM; Eikelboom J; Loeb M; Maggioni AP; Bhatt DL; Yusuf S;
    JAMA Netw Open; 2021 Dec; 4(12):e2141328. PubMed ID: 34964849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 plus ribavirin versus interferon-alpha-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-alpha-2b treatment.
    Malaguarnera M; Pistone G; Neri S; Romano M; Brogna A; Musumeci S
    BioDrugs; 2004; 18(6):407-13. PubMed ID: 15571424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effect of nebulized acetylcysteine inhalation combined with bronchoscopy in the treatment of elderly patients with severe ventilator-associated pneumonia].
    Wu L; Yu YH; Li L; Xu LY; Ruan XX; Lin CB; Zhao JP
    Zhonghua Shao Shang Za Zhi; 2020 Apr; 36(4):267-272. PubMed ID: 32340416
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis.
    Boglione L; Olivieri C; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Biffi S; Borrè S
    Adv Med Sci; 2021 Sep; 66(2):262-268. PubMed ID: 34022675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area.
    Meng Z; Wang T; Chen L; Chen X; Li L; Qin X; Li H; Luo J
    Curr Top Med Chem; 2021; 21(10):920-927. PubMed ID: 33970846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.